Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NL INDUSTRIES INC (NL)

  • Business News
  • Aug. 05, 2026, 20:20 UTC
  • 1
  • 1 comments

NLI HOLDINGS ANNOUNCES QUARTERLY DIVIDEND FOR THE THIRD QUARTER OF 2026 AT $.10 PER SHARE

Market reaction Comment Full text

CROWN CASTLE INC. (CCI)

  • Business News
  • Aug. 05, 2026, 20:20 UTC
  • 1
  • 1 comments

Crown Castle Declares Quarterly Common Stock Dividend

Market reaction Comment Full text

NL INDUSTRIES INC (NL)

  • Business News
  • Aug. 05, 2026, 20:20 UTC
  • 1
  • 1 comments

NLI REPORTS SECOND QUARTER 2026 RESULTS

Market reaction Comment Full text

ENACT HOLDINGS, INC. (ACT)

  • Business News
  • Aug. 05, 2026, 20:20 UTC
  • 0
  • 1 comments

Enact Reports Second Quarter 2026 Results; Announces $0.24 Quarterly Dividend

Market reaction Comment Full text

RAYONIER INC (RYN)

  • Business News
  • Aug. 05, 2026, 20:20 UTC
  • 1
  • 1 comments

Rayonier Completes Transactions to Optimize Timberland Portfolio

Market reaction Comment Full text

TEVA- PHARMACEUTICAL INDUSTRIES LTD. (TEVA)

  • Business News
  • Aug. 05, 2026, 20:18 UTC
  • 1
  • 1 comments

Immediate Report

Market reaction Comment Full text

TEVA- PHARMACEUTICAL INDUSTRIES LTD. (TEVA)

  • Business News
  • Aug. 05, 2026, 20:18 UTC
  • 1
  • 1 comments

Immediate Report

Market reaction Comment Full text

VICI PROPERTIES INC. (VICI)

  • Business News
  • Aug. 05, 2026, 20:18 UTC
  • 1
  • 1 comments

VICI Properties Announces Pricing of Public Offering of $1.75 Billion of Senior Unsecured Notes

Market reaction Comment Full text

SMARTSTOP SELF STORAGE REIT, INC. COMMON STOCK (SMA)

  • Business News
  • Aug. 05, 2026, 20:18 UTC
  • 1
  • 1 comments

SmartStop Self Storage REIT, Inc. Reports Second Quarter 2026 Results

Market reaction Comment Full text

Zomedica Pharmaceuticals Corp (ZOMDF)

  • Business News
  • Aug. 05, 2026, 20:17 UTC
  • 1
  • 1 comments

Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity

Market reaction Comment Full text
  • Previous
  • 293
  • 294
  • 295
  • 296
  • 297
  • Next

Search

News categories

  • Technical Exchange News(14191)
  • Event(6229)
  • SEC News(362003)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222798)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin